Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trial

AIM: Selective serotonin reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitors (SNRI) are effective in treating anxiety disorders associated with major depressive disorder (MDD). This randomized, controlled, parallel-group, open-label, phase 4 trial (CTRI/2012/08/002895) was un...

Descripción completa

Detalles Bibliográficos
Autores principales: Maity, Nabakumar, Ghosal, Malay Kumar, Gupta, Anupam, Sil, Amrita, Chakraborty, Sushmita, Chatterjee, Suparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118540/
https://www.ncbi.nlm.nih.gov/pubmed/25097285
http://dx.doi.org/10.4103/0253-7613.135959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118540/
https://www.ncbi.nlm.nih.gov/pubmed/25097285
http://dx.doi.org/10.4103/0253-7613.135959

Ejemplares similares